Posted On: 09/07/2013 4:12:25 PM
Post# of 250679
Ligand Pharmaceuticals Incorporated LGNXZ Company Overview
Stock Message Board http://investorshangout.com/search?q=LGNXZ&am...mp;yt1=Go!
Ligand Pharmaceuticals Incorporated LGNXZ Current Price and Quotes
Last Price 0.066
Previous Close 0.066 Open 0.066
Daily Range 0.066 - 0.066 52wk Range 0.125 - 0.005
Volume 2,000 Dividend N/A
Average Vol (3m) 6,999 Yield N/A
Ligand Pharmaceuticals Incorporated LGNXZ
Company Information
11119 North Torrey Pines Road
Suite 200
La Jolla, CA 92037
Website: http://www.ligand.com
Phone: 858-550-7500
Ligand Pharmaceuticals Incorporated LGNXZ
Ligand discovers, develops and markets new drugs for critical unmet medical needs in the areas of cancer, pain, skin diseases, hormone-related diseases, osteoporosis, metabolic disorders, cardiovascular and inflammatory diseases. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription technology related to intracellular receptors.
Ligand Pharmaceuticals Incorporated LGNXZ
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Not Available
Latest Report Jun 30, 2013 10-Q
CIK 0000886163
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 1987
Employees 550 a/o Dec 31, 2004
Company Officers/Contacts
David E. Robinson President, CEO
Paul V. Maier CFO
Matthew W. Foehr EVP, COO
Charles S. Berkman Vice President, Secretary, General Counsel
Erika Luib IR
Company Directors
David E. Robinson Chairman
John LaMattina
Sunil Patel
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available
Ligand Pharmaceuticals Incorporated LGNXZ
LGNXZ Security Details Other Company Securities
Share Structure
Market Value1 Not Available
Shares Outstanding Not Available
Float Not Available
Authorized Shares Not Available
Par Value No Par Value
Shareholders
Shareholders of Record Not Available
Short Selling Data
Short Interest 0 (-100%)
Jul 15, 2011
Significant Failures to Deliver No
Transfer Agent(s)
Ligand Pharmaceuticals Incorporated LGNXZ Recent News
Sept 5, 2013 OTC Signal Daily Stock Watch - Ligand Pharmaceuticals Incorporated (NASDAQ: LGND)
Aug 14, 2013 Ligand Enters Global License Agreement with CURx Pharmaceuticals, Inc. for Captisol-Enabled(TM) Topiramate Injection
Aug 1, 2013 Ligand Reports Second Quarter Financial Results
Jul 29, 2013 New License Agreements and Financial Results Release - Research Report on Elan, Waters, InterMune, Spectranetics, and Ligand
Jul 26, 2013 Ligand Partner GlaxoSmithKline Receives Positive CHMP Opinion for REVOLADE(TM) in Thrombocytopenia Associated with Chronic Hepatitis C Infection
Jul 26, 2013 Ligand Receives Orphan Designation for Captisol-Enabled(TM) Topiramate Injection
Jul 24, 2013 Ligand Signs License Agreement with Ethicor for Oral Lasofoxifene
Jul 22, 2013 Ligand Signs Global License Agreement with Azure for Lasofoxifene
Jul 17, 2013 Ligand to Report Second Quarter Results on August 1st
Jun 24, 2013 Ligand Announces Positive Preclinical Data for Glucagon Program in Model of Type 1 Diabetes
1
2
next >
Ligand Pharmaceuticals Incorporated LGNXZ Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 31,388 30,037 23,538 38,940
Cost of Revenue 3,601 4,909 - -
Gross Profit 27,787 25,128 23,538 38,940
Operating Expenses
Research and Development 10,790 10,291 22,067 39,870
Sales, General and Admin. 16,108 13,275 11,127 (6,640)
Non-Recurring Items 315 2,260 19,648 15,677
Other - - - -
Operating Income 574 (698) (29,304) (9,967)
Income From Continuing Operations
Add'l Income/Expense Items (1,134) (383) 13,519 365
Earnings Before Interest and Tax (3,865) (3,558) (15,403) (9,602)
Interest Expense - - - 270
Earnings Before Tax (3,865) (3,558) (15,403) (9,872)
Income Tax (1,191) (13,270) (2,617) (1,535)
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (2,674) 9,712 (12,786) (8,337)
Non Recurring Events
Discontinued Operations 2,147 3 2,413 6,389
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (527) 9,715 (10,373) (1,948)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (527) 9,715 (10,373) (1,948)
LGNXZ Ligand Pharmaceuticals Incorporated Research DD Guide
LGNXZ Ligand Pharmaceuticals Incorporated Stock Message Board http://investorshangout.com/search?q=LGNXZ&am...mp;yt0=Go!
LGNXZ Ligand Pharmaceuticals Incorporated Stock Quote http://www.otcmarkets.com/stock/LGNXZ/quote
LGNXZ Ligand Pharmaceuticals Incorporated Stock Chart http://www.otcmarkets.com/stock/LGNXZ/chart
LGNXZ Ligand Pharmaceuticals Incorporated Company Info http://www.otcmarkets.com/stock/LGNXZ/company-info
LGNXZ Ligand Pharmaceuticals Incorporated Recent News http://www.otcmarkets.com/stock/LGNXZ/news
LGNXZ Ligand Pharmaceuticals Incorporated Financials http://www.otcmarkets.com/stock/LGNXZ/financials
LGNXZ Ligand Pharmaceuticals Incorporated Filings and Disclosure http://www.otcmarkets.com/stock/LGNXZ/filings
LGNXZ Ligand Pharmaceuticals Incorporated Short Sales http://www.otcmarkets.com/stock/LGNXZ/short-sales
LGNXZ Ligand Pharmaceuticals Incorporated Insider Disclosure http://www.otcmarkets.com/stock/LGNXZ/insider-transactions
LGNXZ Ligand Pharmaceuticals Incorporated Research Reports http://www.otcmarkets.com/stock/LGNXZ/research
LGNXZ Ligand Pharmaceuticals Incorporated Summary http://finance.yahoo.com/q?s=LGNXZ
LGNXZ Ligand Pharmaceuticals Incorporated Historical Prices http://finance.yahoo.com/q/hp?s=LGNXZ+Historical+Prices
LGNXZ Ligand Pharmaceuticals Incorporated Interactive Chart http://finance.yahoo.com/echarts?s=LGNXZ
LGNXZ Ligand Pharmaceuticals Incorporated Basic Chart http://finance.yahoo.com/q/bc?s=LGNXZ+Basic+Chart
LGNXZ Ligand Pharmaceuticals Incorporated Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=LGNXZ+Basic+Tech.+Analysis
LGNXZ Ligand Pharmaceuticals Incorporated Headlines http://finance.yahoo.com/q/h?s=LGNXZ+Headlines
LGNXZ Ligand Pharmaceuticals Incorporated Press Releases http://finance.yahoo.com/q/p?s=LGNXZ+Press+Releases
LGNXZ Ligand Pharmaceuticals Incorporated Company Profile http://finance.yahoo.com/q/pr?s=LGNXZ+Profile
LGNXZ Ligand Pharmaceuticals Incorporated Key Statistics http://finance.yahoo.com/q/ks?s=LGNXZ+Key+Statistics
LGNXZ Ligand Pharmaceuticals Incorporated Industry http://finance.yahoo.com/q/in?s=LGNXZ+Industry
LGNXZ Ligand Pharmaceuticals Incorporated Major Holders http://finance.yahoo.com/q/mh?s=LGNXZ+Major+Holders
LGNXZ Ligand Pharmaceuticals Incorporated Insider Transactions http://finance.yahoo.com/q/it?s=LGNXZ+Insider+Transactions
LGNXZ Ligand Pharmaceuticals Incorporated Insider Roster http://finance.yahoo.com/q/ir?s=LGNXZ+Insider+Roster
LGNXZ Ligand Pharmaceuticals Incorporated Income Statement http://finance.yahoo.com/q/is?s=LGNXZ
LGNXZ Ligand Pharmaceuticals Incorporated Balance Sheet http://finance.yahoo.com/q/bs?s=LGNXZ
LGNXZ Ligand Pharmaceuticals Incorporated Cash Flow http://finance.yahoo.com/q/cf?s=LGNXZ+Cash+Flow&annual
LGNXZ Ligand Pharmaceuticals Incorporated Nasdaq http://www.nasdaq.com/symbol/LGNXZ
LGNXZ Ligand Pharmaceuticals Incorporated Market Watch http://www.marketwatch.com/investing/stock/LGNXZ
LGNXZ Ligand Pharmaceuticals Incorporated Bloomberg http://www.bloomberg.com/quote/LGNXZ:US
LGNXZ Ligand Pharmaceuticals Incorporated Morningstar http://quotes.morningstar.com/stock/s?t=LGNXZ
LGNXZ Ligand Pharmaceuticals Incorporated Bussinessweek http://investing.businessweek.com/research/st...cker=LGNXZ
LGNXZ Ligand Pharmaceuticals Incorporated Barchart http://www.barchart.com/quotes/stocks/LGNXZ
LGNXZ Ligand Pharmaceuticals Incorporated OTC Short Report http://otcshortreport.com/index.php?index=LGNXZ
LGNXZ Ligand Pharmaceuticals Incorporated Investopedia http://www.investopedia.com/markets/stocks/LGNXZ/?wa=0
List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Stock Message Board http://investorshangout.com/search?q=LGNXZ&am...mp;yt1=Go!
Ligand Pharmaceuticals Incorporated LGNXZ Current Price and Quotes
Last Price 0.066
Previous Close 0.066 Open 0.066
Daily Range 0.066 - 0.066 52wk Range 0.125 - 0.005
Volume 2,000 Dividend N/A
Average Vol (3m) 6,999 Yield N/A
Ligand Pharmaceuticals Incorporated LGNXZ
Company Information
11119 North Torrey Pines Road
Suite 200
La Jolla, CA 92037
Website: http://www.ligand.com
Phone: 858-550-7500
Ligand Pharmaceuticals Incorporated LGNXZ
Ligand discovers, develops and markets new drugs for critical unmet medical needs in the areas of cancer, pain, skin diseases, hormone-related diseases, osteoporosis, metabolic disorders, cardiovascular and inflammatory diseases. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription technology related to intracellular receptors.
Ligand Pharmaceuticals Incorporated LGNXZ
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Not Available
Latest Report Jun 30, 2013 10-Q
CIK 0000886163
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 1987
Employees 550 a/o Dec 31, 2004
Company Officers/Contacts
David E. Robinson President, CEO
Paul V. Maier CFO
Matthew W. Foehr EVP, COO
Charles S. Berkman Vice President, Secretary, General Counsel
Erika Luib IR
Company Directors
David E. Robinson Chairman
John LaMattina
Sunil Patel
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available
Ligand Pharmaceuticals Incorporated LGNXZ
LGNXZ Security Details Other Company Securities
Share Structure
Market Value1 Not Available
Shares Outstanding Not Available
Float Not Available
Authorized Shares Not Available
Par Value No Par Value
Shareholders
Shareholders of Record Not Available
Short Selling Data
Short Interest 0 (-100%)
Jul 15, 2011
Significant Failures to Deliver No
Transfer Agent(s)
Ligand Pharmaceuticals Incorporated LGNXZ Recent News
Sept 5, 2013 OTC Signal Daily Stock Watch - Ligand Pharmaceuticals Incorporated (NASDAQ: LGND)
Aug 14, 2013 Ligand Enters Global License Agreement with CURx Pharmaceuticals, Inc. for Captisol-Enabled(TM) Topiramate Injection
Aug 1, 2013 Ligand Reports Second Quarter Financial Results
Jul 29, 2013 New License Agreements and Financial Results Release - Research Report on Elan, Waters, InterMune, Spectranetics, and Ligand
Jul 26, 2013 Ligand Partner GlaxoSmithKline Receives Positive CHMP Opinion for REVOLADE(TM) in Thrombocytopenia Associated with Chronic Hepatitis C Infection
Jul 26, 2013 Ligand Receives Orphan Designation for Captisol-Enabled(TM) Topiramate Injection
Jul 24, 2013 Ligand Signs License Agreement with Ethicor for Oral Lasofoxifene
Jul 22, 2013 Ligand Signs Global License Agreement with Azure for Lasofoxifene
Jul 17, 2013 Ligand to Report Second Quarter Results on August 1st
Jun 24, 2013 Ligand Announces Positive Preclinical Data for Glucagon Program in Model of Type 1 Diabetes
1
2
next >
Ligand Pharmaceuticals Incorporated LGNXZ Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 31,388 30,037 23,538 38,940
Cost of Revenue 3,601 4,909 - -
Gross Profit 27,787 25,128 23,538 38,940
Operating Expenses
Research and Development 10,790 10,291 22,067 39,870
Sales, General and Admin. 16,108 13,275 11,127 (6,640)
Non-Recurring Items 315 2,260 19,648 15,677
Other - - - -
Operating Income 574 (698) (29,304) (9,967)
Income From Continuing Operations
Add'l Income/Expense Items (1,134) (383) 13,519 365
Earnings Before Interest and Tax (3,865) (3,558) (15,403) (9,602)
Interest Expense - - - 270
Earnings Before Tax (3,865) (3,558) (15,403) (9,872)
Income Tax (1,191) (13,270) (2,617) (1,535)
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (2,674) 9,712 (12,786) (8,337)
Non Recurring Events
Discontinued Operations 2,147 3 2,413 6,389
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (527) 9,715 (10,373) (1,948)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (527) 9,715 (10,373) (1,948)
LGNXZ Ligand Pharmaceuticals Incorporated Research DD Guide
LGNXZ Ligand Pharmaceuticals Incorporated Stock Message Board http://investorshangout.com/search?q=LGNXZ&am...mp;yt0=Go!
LGNXZ Ligand Pharmaceuticals Incorporated Stock Quote http://www.otcmarkets.com/stock/LGNXZ/quote
LGNXZ Ligand Pharmaceuticals Incorporated Stock Chart http://www.otcmarkets.com/stock/LGNXZ/chart
LGNXZ Ligand Pharmaceuticals Incorporated Company Info http://www.otcmarkets.com/stock/LGNXZ/company-info
LGNXZ Ligand Pharmaceuticals Incorporated Recent News http://www.otcmarkets.com/stock/LGNXZ/news
LGNXZ Ligand Pharmaceuticals Incorporated Financials http://www.otcmarkets.com/stock/LGNXZ/financials
LGNXZ Ligand Pharmaceuticals Incorporated Filings and Disclosure http://www.otcmarkets.com/stock/LGNXZ/filings
LGNXZ Ligand Pharmaceuticals Incorporated Short Sales http://www.otcmarkets.com/stock/LGNXZ/short-sales
LGNXZ Ligand Pharmaceuticals Incorporated Insider Disclosure http://www.otcmarkets.com/stock/LGNXZ/insider-transactions
LGNXZ Ligand Pharmaceuticals Incorporated Research Reports http://www.otcmarkets.com/stock/LGNXZ/research
LGNXZ Ligand Pharmaceuticals Incorporated Summary http://finance.yahoo.com/q?s=LGNXZ
LGNXZ Ligand Pharmaceuticals Incorporated Historical Prices http://finance.yahoo.com/q/hp?s=LGNXZ+Historical+Prices
LGNXZ Ligand Pharmaceuticals Incorporated Interactive Chart http://finance.yahoo.com/echarts?s=LGNXZ
LGNXZ Ligand Pharmaceuticals Incorporated Basic Chart http://finance.yahoo.com/q/bc?s=LGNXZ+Basic+Chart
LGNXZ Ligand Pharmaceuticals Incorporated Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=LGNXZ+Basic+Tech.+Analysis
LGNXZ Ligand Pharmaceuticals Incorporated Headlines http://finance.yahoo.com/q/h?s=LGNXZ+Headlines
LGNXZ Ligand Pharmaceuticals Incorporated Press Releases http://finance.yahoo.com/q/p?s=LGNXZ+Press+Releases
LGNXZ Ligand Pharmaceuticals Incorporated Company Profile http://finance.yahoo.com/q/pr?s=LGNXZ+Profile
LGNXZ Ligand Pharmaceuticals Incorporated Key Statistics http://finance.yahoo.com/q/ks?s=LGNXZ+Key+Statistics
LGNXZ Ligand Pharmaceuticals Incorporated Industry http://finance.yahoo.com/q/in?s=LGNXZ+Industry
LGNXZ Ligand Pharmaceuticals Incorporated Major Holders http://finance.yahoo.com/q/mh?s=LGNXZ+Major+Holders
LGNXZ Ligand Pharmaceuticals Incorporated Insider Transactions http://finance.yahoo.com/q/it?s=LGNXZ+Insider+Transactions
LGNXZ Ligand Pharmaceuticals Incorporated Insider Roster http://finance.yahoo.com/q/ir?s=LGNXZ+Insider+Roster
LGNXZ Ligand Pharmaceuticals Incorporated Income Statement http://finance.yahoo.com/q/is?s=LGNXZ
LGNXZ Ligand Pharmaceuticals Incorporated Balance Sheet http://finance.yahoo.com/q/bs?s=LGNXZ
LGNXZ Ligand Pharmaceuticals Incorporated Cash Flow http://finance.yahoo.com/q/cf?s=LGNXZ+Cash+Flow&annual
LGNXZ Ligand Pharmaceuticals Incorporated Nasdaq http://www.nasdaq.com/symbol/LGNXZ
LGNXZ Ligand Pharmaceuticals Incorporated Market Watch http://www.marketwatch.com/investing/stock/LGNXZ
LGNXZ Ligand Pharmaceuticals Incorporated Bloomberg http://www.bloomberg.com/quote/LGNXZ:US
LGNXZ Ligand Pharmaceuticals Incorporated Morningstar http://quotes.morningstar.com/stock/s?t=LGNXZ
LGNXZ Ligand Pharmaceuticals Incorporated Bussinessweek http://investing.businessweek.com/research/st...cker=LGNXZ
LGNXZ Ligand Pharmaceuticals Incorporated Barchart http://www.barchart.com/quotes/stocks/LGNXZ
LGNXZ Ligand Pharmaceuticals Incorporated OTC Short Report http://otcshortreport.com/index.php?index=LGNXZ
LGNXZ Ligand Pharmaceuticals Incorporated Investopedia http://www.investopedia.com/markets/stocks/LGNXZ/?wa=0
List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
(0)
(0)
